Since 1965, we have been continuously supporting the progress of cancer research, thanks to fundraising, and we have informed the public on the results achieved, on their potential for treatment, and on prevention.
At the core of our mission lies a common set of shared values and principles. AIRC contributes to the progress of oncology promoting young talents, supporting the most innovative research projects, and investing in cutting-edge technologies.
We are Italy’s main private funding hub for cancer research: in 2022 we allocated €137 million to this activity.
Every day, in Italy, an average of 1,000 people are diagnosed with cancer.
Data for 2022, the latest available, estimate 390.700 total cases (205.000 in men and 185.700 in women). Rates of incidence for melanoma and pancreatic tumors are rising in both sexes. It is confirmed that cases of lung cancer are increasing among women – but decreasing in men – and a slight growth is highlighted in breast tumors, too.
These figures provide a clear picture of the social impact of a disease such as cancer, which still requires a great deal of research in order to find new treatments for those who are fighting their battle today, and for those who will get sick in the future.
We rely on internal and external stakeholders to carry out our mission. Each brings their own instruments and methods to contribute to the progress of research — researchers pursue an ethical and professional purpose, while supporters, volunteers, and partners support their work.
We can count on the help of the media, institutions, testimonials, and schools to spread our message: a virtuous circle that allows the whole community to benefit from the progress of research, and viceversa.